Loading...

Malaysia's medtech industry to generate USD2.7 bn

Image

02-Aug-16 Malaysia’s medical devices sector is expected to contribute MYR11 bn (USD2.7 bn) in exports in 2016, with revenue from the health tourism and pharmaceutical sectors expected to reach MYR1 bn (USD248 mn) and MYR800 mn (USD199 mn) respectively. Malaysia is the largest surgical gloves manufacturer in the world and also makes beds, dental chairs and orthopaedic implants. [image: Free Malaysia Today]

Read More

China's first medical 3D printing factory to open

Image

22-Jul-16 Hkable Biological 3D and the China’s Fengdu County government have signed an agreement which will see them build China’s first 3D printing factory for medical products. The factory will be located in the municipality of Chongqing, Southwest China. [image: 3ders.org]

Read More

Indian government plans to table Medical Device Act

Image

19-Jul-16 India's government is planning to table a new Medical Device Act in the forthcoming winter session of Parliament. In a 11-Jul-16 meeting on the Make in India initiative for medical devices, attended by leading associations, issues such as ease of doing business, regulation, fiscal imperatives, scaling manufacturing, promoting exports, encouraging innovations and making India attractive for investment were discussed. [image: Business Standard]

Read More

China may end India's drug trade dominance

Image

05-Jul-16 India is making steady progress in the export of drugs around the world. India's Commerce & Industry Ministry said "India's pharmaceutical exports continued their lead over China in 2015." However, experts warn this trend will wane if Indian firms continue to depend on Chinese raw materials. [image: Pixabay]

Read More

Report outlines reforms for China's pharmaceutical system

Image

07-Jul-16 China’s pharmaceutical system will struggle to cope with a rapidly aging population and increases in non-communicable diseases says a report by LSE Health and the State Council. The report identifies market fragmentation as a major challenge, with the top five manufacturers holding <15% market share, and finds R&D accounts for only 2% of sales, compared with 14-18% for MNC pharma companies. [image: LSE]

Read More
Share